Granules India Ltd
NSE:GRANULES
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Granules India Ltd
NSE:GRANULES
|
IN |
|
Ador Fontech Ltd
BSE:530431
|
IN |
|
QYOU Media Inc
XTSX:QYOU
|
CA |
|
Westone Information Industry Inc
SZSE:002268
|
CN |
|
G
|
Graycliff Exploration Ltd
CNSX:GRAY
|
CA |
|
N
|
Nikki Co Ltd
TSE:6042
|
JP |
|
E
|
Excel Realty N Infra Ltd
NSE:EXCEL
|
IN |
|
M
|
Mabuhay Holdings Corp
XPHS:MHC
|
PH |
|
S
|
SUFA Technology Industry Co Ltd CNNC
SZSE:000777
|
CN |
|
TPG Pace Solutions Corp
NASDAQ:VCSA
|
US |
|
H
|
Hangzhou Zhongtai Cryogenic Technology Corp
SZSE:300435
|
CN |
|
X
|
Xinjiang Tianrun Dairy Co Ltd
SSE:600419
|
CN |
|
Capital Clean Energy Carriers Corp
NASDAQ:CCEC
|
GR |
|
A
|
Alphalogic Industries Ltd
BSE:543937
|
IN |
|
T
|
Tian Teck Land Ltd
HKEX:266
|
HK |
|
Blackrock Silver Corp
XTSX:BRC
|
CA |
|
M&G PLC
LSE:MNG
|
UK |
|
Smoore International Holdings Ltd
HKEX:6969
|
CN |
|
X
|
Xilinx Inc
LSE:0M1U
|
US |
|
Matahari Department Store Tbk PT
IDX:LPPF
|
ID |
|
Owens & Minor Inc
NYSE:OMI
|
US |
|
American Tower Corp
NYSE:AMT
|
US |
|
Dentsu Group Inc
TSE:4324
|
JP |
Relative Value
The Relative Value of one
GRANULES
stock under the Base Case scenario is
hidden
INR.
Compared to the current market price of 629.05 INR,
Granules India Ltd
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
GRANULES Competitors Multiples
Granules India Ltd Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IN |
|
Granules India Ltd
NSE:GRANULES
|
152.7B INR | 3 | 28 | 14.1 | 18.7 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
865.7B USD | 13.3 | 41.9 | 28.3 | 30.2 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
577.7B USD | 6.1 | 21.6 | 15 | 18.4 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
243.4B CHF | 4 | 18.9 | 11.2 | 12.6 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
295.4B USD | 4.5 | 16.2 | 10 | 12.2 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
214.2B GBP | 5 | 28.6 | 15.9 | 22.4 | |
| CH |
|
Novartis AG
SIX:NOVN
|
225.4B CHF | 5.2 | 21.1 | 13.1 | 16.8 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.4 | 7.7 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
155.1B USD | 2.5 | 20 | 7.7 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
118.6B USD | 2.5 | 16.8 | 7.1 | 8.8 |